Search Results

You searched for : GvHD

	Lupin Launches Posaconazole Delayed-Release Tablets Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
	Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
	First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT) Orca Bio, today announced the first clinical data from its first-generation investigational therapy,... Dec 07
	Health Canada Clears CytoDyn to File its BLA for Leronlimab as One Injection per Week for Combination HIV Therapy Health Canada has cleared CytoDyn to file its Biologics License Application (BLA) for leronlimab as a combination therapy for multi-drug resistance HIV patients in ... Nov 16
	Phase 3 Osteoarthritis Clinical Trial Commences Cynata Therapeutics announces that the Phase 3 Osteoarthritis Clinical Trial..... Nov 12
	Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke... Oct 27
	U.K. MHRA Clears CytoDyn to File its BLA for Leronlimab as One Injection per Week for Combination HIV Therapy MHRA of the U.K. government has cleared CytoDyn to file its Biologics License Application (BLA) for leronlimab as a combination therapy for multi-drug ... Oct 27
	Stem Cell therapy has long lasting Neurological benefits Researchers show that stem cell therapy has a better and long-lasting effect on Neurological disorders.... Mar 19
8 Matching result(s) found!

-Advertisements-

Trending Now
	FLO organized a session with two of the top VCs in India on "The Journey of an Idea"June 06, 2024
	FTCCI organised a Workshop on "Opportunities in Food Processing"June 06, 2024
	Roundtable conference on Ethical Business Practices heldJune 06, 2024
	Magniflex India makes a sustainable leap forward with the launch of MagnigeoJune 06, 2024
	Unlocking the Secrets of Sleep: How Rest Impacts Brain Health and Waste RemovalJune 06, 2024
	ICMR Warns Against Overheating Non-Stick Pans: Tips to Prevent Toxin ExposureJune 06, 2024
	Promising New HIV Vaccine Candidate Shows Early Success: A Hopeful Step in HIV ResearchJune 06, 2024
	MAGGI makes an appeal on World Environment Day: ‘2-Min for the Environment: Everyone. Everyday.’June 05, 2024
	HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver CongressJune 05, 2024
	FSSAI Enforces Transparency: No More '100% Fruit Juice' Claims on Reconstituted ProductsJune 05, 2024
	Is Omega-3 Fatty Acid and Fish Oil Good for Your Heart? Recent Study Suggest Mixed ResultsJune 05, 2024
	Neonatal Unit Fire: Court Dismisses Bail for Unqualified Ayurvedic DoctorJune 05, 2024
	Protect the medicines that protect usJune 04, 2024
	New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for BiotechsJune 04, 2024
	Indonesia is enforcing stronger anti-tobacco measures despite industry interferenceJune 04, 2024
	How will a NDA win in Lok Sabha polls impact healthcare market June 04, 2024
	Strokes Aren’t Just for the Elderly: A 33-Year-Old’s Survival StoryJune 04, 2024
	From Lower Back Pain to Cardiovascular Disease: Addressing the Health Divide Between Men and WomenJune 04, 2024
	Attack on Doctor at GB Hospital Sparks Outrage in Medical CommunityJune 04, 2024
	How Age Discrimination Impacts Indian Employees: A Closer LookJune 04, 2024

Search Results

Lupin Launches Posaconazole Delayed-Release Tablets

Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm

First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

Health Canada Clears CytoDyn to File its BLA for Leronlimab as One Injection per Week for Combination HIV Therapy

Phase 3 Osteoarthritis Clinical Trial Commences

Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke

U.K. MHRA Clears CytoDyn to File its BLA for Leronlimab as One Injection per Week for Combination HIV Therapy

Stem Cell therapy has long lasting Neurological benefits

Trending Now